BioMarin Pharmaceutical | BMRN - درآمد حاصل از بهره





درآمد حاصل از بهره تغییر دادن تاریخ
Acadia Pharmaceuticals USD 8.25M 1M 2025-09
Agios Pharmaceuticals USD 13.37M 1.14M 2025-09
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
Bayer EUR 130M 38M 2025-09
Biogen USD 31.6M 700K 2025-09
BioMarin Pharmaceutical USD 17.85M 973K 2025-09
Gilead Sciences USD 88M 15M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Insmed USD 765K 55K 2024-09
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 73M 8M 2025-09
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sanofi EUR 114M 38M 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
United Therapeutics USD 46.4M 4.9M 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09